 |
|
Home | GlaxoSmithKline plc Earns “Underperform” Rating from Credit Suisse (GSK) |
 |
GlaxoSmithKline plc Earns “Underperform” Rating from Credit Suisse (GSK)
|
 |
- October 18, 2014
-
GlaxoSmithKline plc (NYSE:GSK)‘s stock had its “underperform” rating reaffirmed by stock analysts at Credit Suisse in a report issued on Wednesday. Shares of GlaxoSmithKline plc (NYSE:GSK) traded down 1.26% on Wednesday, hitting $43.13. 7,547,565 shares of the company’s stock traded hands. GlaxoSmithKline plc has a 52 week low of $43.58 and a 52 week high […]This article (GlaxoSmithKline plc Earns “Underperform” Rating from Credit Suisse (GSK)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/10/15/glaxosmithkline-plc-earns-underperform-rating-from-credit-suisse-gsk-2/
|
 |
|
 |
|
 |
